본문 바로가기
KERD
논문KCI 등재

Inflammatory Cerebral Amyloid Angiopathy: A Broad Clinical Spectrum

Aaron de Souza|Kate Tasker
대한신경과학회 (Korean Neurological Association)|2023.05|Journal of Clinical Neurology|제19권 제3호|pp. 230-241

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

strokevasculitisseizurescerebral amyloid angiopathycerebral amyloid angiopathy related inflammationamyloid-beta related angiitisencephalopathy.

초록

Cerebral amyloid angiopathy (CAA) is a common central nervous system (CNS) vasculopathy, which in some cases is associated with subacute encephalopathy, seizures, headaches, or strokes due to vascular inflammation directed against vascular amyloid accumulation. The pathological subtypes of inflammatory CAA include CAA-related inflammation (CAAri) with mostly perivascular lymphocytic infiltrates, or amyloid-beta (Aβ)-related angiitis (ABRA) with transmural granulomatous inflammation. CAAri and ABRA probably represent part of the spectrum of CNS vasculopathies, intermediate between CAA and primary CNS vasculitis, and they are closely related to Aβ-related imaging abnormalities and other manifestations of an inflammatory response directed against Aβ in the leptomeninges and cerebral parenchyma. As treatment strategies in Alzheimer’s disease shift toward potentially effective antiamyloid immunotherapy, the incidence rate of inflammatory CAA (which is probably an underrecognized condition) is likely to increase. Its clinical features are varied and include subacute encephalopathy, behavioral symptoms, headaches, seizures, and focal neurological deficits, which necessitate a high degree of suspicion for this disorder that often responds to treatment. The recent definition of the typical clinical and radiological syndrome has increased its recognition and may eliminate the need for invasive histological sampling in at least some affected patients. Here we review the pathophysiology, clinical spectrum, and approach to diagnosis, and discuss illustrative cases that highlight the wide range of clinical presentations.

Abstract

Cerebral amyloid angiopathy (CAA) is a common central nervous system (CNS) vasculopathy, which in some cases is associated with subacute encephalopathy, seizures, headaches, or strokes due to vascular inflammation directed against vascular amyloid accumulation. The pathological subtypes of inflammatory CAA include CAA-related inflammation (CAAri) with mostly perivascular lymphocytic infiltrates, or amyloid-beta (Aβ)-related angiitis (ABRA) with transmural granulomatous inflammation. CAAri and ABRA probably represent part of the spectrum of CNS vasculopathies, intermediate between CAA and primary CNS vasculitis, and they are closely related to Aβ-related imaging abnormalities and other manifestations of an inflammatory response directed against Aβ in the leptomeninges and cerebral parenchyma. As treatment strategies in Alzheimer’s disease shift toward potentially effective antiamyloid immunotherapy, the incidence rate of inflammatory CAA (which is probably an underrecognized condition) is likely to increase. Its clinical features are varied and include subacute encephalopathy, behavioral symptoms, headaches, seizures, and focal neurological deficits, which necessitate a high degree of suspicion for this disorder that often responds to treatment. The recent definition of the typical clinical and radiological syndrome has increased its recognition and may eliminate the need for invasive histological sampling in at least some affected patients. Here we review the pathophysiology, clinical spectrum, and approach to diagnosis, and discuss illustrative cases that highlight the wide range of clinical presentations.

참고문헌 (98)

  1. Raghavan P, "Cerebral amyloid angiopathy-related inflammation : a potentially reversible cause of dementia with characteristic imaging findings", J Neuroradiol, 43, pp.11~17 (2016)
  2. Revesz T, "Cerebral amyloid angiopathies : a pathologic, biochemical, and genetic view", J Neuropathol Exp Neurol, 62, pp.885~898 (2003)
  3. Chwalisz BK, "Cerebral amyloid angiopathy and related inflammatory disorders", J Neurol Sci, 424, pp.117425~ (2021)
  4. Alessandro Biffi, "Cerebral Amyloid Angiopathy: A Systematic Review", Journal of Clinical Neurology, 7(1), pp.1~9 (2011), 대한신경과학회
  5. Henry-Feugeas MC, "MRI of the ‘Alzheimer syndrome’", J Neuroradiol, 34, pp.220~227 (2007)
  6. Attems J, "Review : sporadic cerebral amyloid angiopathy", Neuropathol Appl Neurobiol, 37, pp.75~93 (2011)
  7. Kirshner HS, "The inflammatory form of cerebral amyloid angiopathy or"cerebral amyloid angiopathy-related inflammation"(CAARI)", Curr Neurol Neurosci Rep, 15, pp.54~ (2015)
  8. Salvarani C, "Aβ-related angiitis : comparison with CAA without inflammation and primary CNS vasculitis", Neurology, 81, pp.1596~1603 (2013)
  9. Greenberg SM, "Cerebral amyloid angiopathy : prospects for clinical diagnosis and treatment", Neurology, 51, pp.690~694 (1998)
  10. Vinters HV, "Cerebral amyloid angiopathy. A critical review", Stroke, 18, pp.311~324 (1987)
  11. Claudia Uribe Roca, "Pseudotumoral Presentation of Cerebral Amyloid-Beta Angiopathy: Case Report and Review of Literature", PSYCHIATRY INVESTIGATION, 18(6), pp.479~485 (2021), 대한신경정신의학회[DOI]
  12. Arvanitakis Z, "Cerebral amyloid angiopathy pathology and cognitive domains in older persons", Ann Neurol, 69, pp.320~327 (2011)
  13. Haacke EM, "Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging", AJNR Am J Neuroradiol, 28, pp.316~317 (2007)
  14. Wu JJ, "Cerebral amyloid angiopathy-related inflammation:current status and future implications", Chin Med J(Engl), 134, pp.646~654 (2021)
  15. Wermer MJH, "The growing clinical spectrum of cerebral amyloid angiopathy", Curr Opin Neurol, 31, pp.28~35 (2018)
  16. Greenberg SM, "The clinical spectrum of cerebral amyloid angiopathy : presentations without lobar hemorrhage", Neurology, 43, pp.2073~2079 (1993)
  17. Smith EE, "Clinical diagnosis of cerebral amyloid angiopathy : validation of the Boston criteria", Curr Atheroscler Rep, 5, pp.260~266 (2003)
  18. Pfeifer LA, "Cerebral amyloid angiopathy and cognitive function : the HAAS autopsy study", Neurology, 58, pp.1629~1634 (2002)
  19. Olichney JM, "Cerebral infarction in Alzheimer’s disease is associated with severe amyloid angiopathy and hypertension", Arch Neurol, 52, pp.702~708 (1995)
  20. Chu S, "Cerebral amyloid angiopathy(CAA)-related inflammation : comparison of inflammatory CAA and amyloid-β-related angiitis", J Alzheimers Dis, 51, pp.525~532 (2016)
  21. Ronsin S, "Pseudotumoral presentation of cerebral amyloid angiopathy-related inflammation", Neurology, 86, pp.912~919 (2016)
  22. Martucci M, "Cerebral amyloid angiopathy-related inflammation : imaging findings and clinical outcome", Neuroradiology, 56, pp.283~289 (2014)
  23. Eng JA, "Clinical manifestations of cerebral amyloid angiopathy-related inflammation", Ann Neurol, 55, pp.250~256 (2004)
  24. Kinnecom C, "Course of cerebral amyloid angiopathy-related inflammation", Neurology, 68, pp.1411~1416 (2007)
  25. Ringheim GE, "Neurodegenerative disease and the neuroimmune axis(Alzheimer’s and Parkinson’s disease, and viral infections)", J Neuroimmunol, 147, pp.43~49 (2004)
  26. Schenk D, "Amyloid-beta immunotherapy for Alzheimer’s disease : the end of the beginning", Nat Rev Neurosci, 3, pp.824~828 (2002)
  27. Castro Caldas A, "Cerebral amyloid angiopathy associated with inflammation : report of 3 cases and systematic review", J Stroke Cerebrovasc Dis, 24, pp.2039~2048 (2015)
  28. Watanabe Y, "Disseminated cerebral amyloid angiopathy-related Inflammation manifesting as non-convulsive status epilepticus", Neurol Clin Neurosci, 5, pp.65~67 (2017)
  29. Salvarani C, "Imaging findings of cerebral amyloid angiopathy, Aβ-related angiitis (ABRA), and cerebral amyloid angiopathy-related inflammation:a single-institution 25-year experience", Medicine(Baltimore), 95, pp.e3613~ (2016)
  30. Scolding NJ, "Abeta-related angiitis : primary angiitis of the central nervous system associated with cerebral amyloid angiopathy", Brain, 128(Pt 3), pp.500~515 (2005)
  31. Salvarani C, "Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy", Rheumatology(Oxford), 47, pp.1671~1677 (2008)
  32. McCarron MO, "The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage", J Neuropathol Exp Neurol, 58, pp.711~718 (1999)
  33. Nicoll JA, "High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy", Ann Neurol, 41, pp.716~721 (1997)
  34. O’Donnell HC, "Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage", N Engl J Med, 342, pp.240~245 (2000)
  35. Masuda J, "Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan", Stroke, 19, pp.205~210 (1988)
  36. Antolini L, "Spontaneous ARIA-like events in cerebral amyloid angiopathy-related inflammation : a multicenter prospective longitudinal cohort study", Neurology, 97, pp.e1809~e1822 (2021)
  37. Chung KK, "Cerebral amyloid angiopathy related inflammation : three case reports and a review", J Neurol Neurosurg Psychiatry, 82, pp.20~26 (2011)
  38. Sakai K, "Nationwide survey on cerebral amyloid angiopathy in Japan", Eur J Neurol, 26, pp.1487~1493 (2019)
  39. Corovic A, "Cerebral amyloid angiopathy associated with inflammation : a systematic review of clinical and imaging features and outcome", Int J Stroke, 13, pp.257~267 (2018)
  40. Banerjee G, "Minimally symptomatic cerebral amyloid angiopathy-related inflammation : three descriptive case reports", J Neurol Neurosurg Psychiatry, 90, pp.113~115 (2019)
  41. Auriel E, "Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation", JAMA Neurol, 73, pp.197~202 (2016)
  42. Tominaga K, "Slowly progressive cerebral amyloid angiopathy-related inflammation : characteristic findings of sequential magnetic resonance imaging", Clin Neurol Neurosurg, 197, pp.106198~ (2020)
  43. McGeer PL, "The inflammatory response system of brain : implications for therapy of Alzheimer and other neurodegenerative diseases", Brain Res Brain Res Rev, 21, pp.195~218 (1995)
  44. Traschütz A, "Reduction of microbleeds by immunosuppression in a patient with Aβ-related vascular inflammation", Neurol Neuroimmunol Neuroinflamm, 2, pp.e165~ (2015)
  45. Melzer N, "CD4(+)T cells predominate in cerebrospinal fluid and leptomeningeal and parenchymal infiltrates in cerebral amyloid β-related angiitis", Arch Neurol, 69, pp.773~777 (2012)
  46. Renard D, "Cerebrospinal fluid, MRI, and florbetaben-PET in cerebral amyloid angiopathy-related inflammation", J Alzheimers Dis, 61, pp.1107~1117 (2018)
  47. Danve A, "Amyloid beta-related angiitis--a case report and comprehensive review of literature of 94 cases", Semin Arthritis Rheum, 44, pp.86~92 (2014)
  48. Harkness KA, "Rapidly reversible dementia in cerebral amyloid inflammatory vasculopathy", Eur J Neurol, 11, pp.59~62 (2004)
  49. Anders KH, "Giant cell arteritis in association with cerebral amyloid angiopathy : immunohistochemical and molecular studies", Hum Pathol, 28, pp.1237~1246 (1997)
  50. Savoiardo M, "Cerebral amyloid angiopathy-related inflammation : an emerging disease", Neuroradiol J, 24, pp.253~257 (2011)
  51. Szpak GM, "Inflammatory cerebral amyloid angiopathy : the overlap of perivascular(PAN-like)with vasculitic(Aβ-related angiitis)form : an autopsy case", Folia Neuropathol, 49, pp.335~347 (2011)
  52. Moussaddy A, "Inflammatory cerebral amyloid angiopathy, amyloid-β-related angiitis, and primary angiitis of the central nervous system : similarities and differences", Stroke, 46, pp.e210~e213 (2015)
  53. Salam S, "Relapsing cerebral amyloid angiopathy-related inflammation : the wax and the wane", Pract Neurol, 17, pp.392~395 (2017)
  54. Probst A, "Amyloid angiopathy combined with granulomatous angiitis of the central nervous system : report on two patients", Clin Neuropathol, 4, pp.250~259 (1985)
  55. Fountain NB, "Control of primary angiitis of the CNS associated with cerebral amyloid angiopathy by cyclophosphamide alone", Neurology, 52, pp.660~662 (1999)
  56. Bogner S, "Immune activation in amyloid-β-related angiitis correlates with decreased parenchymal amyloid-β plaque load", Neurodegener Dis, 13, pp.38~44 (2014)
  57. Moosavi B, "Case 232 : amyloid β-related angiitis", Radiology, 280, pp.643~647 (2016)
  58. Charidimou A, "Sporadic cerebral amyloid angiopathy revisited : recent insights into pathophysiology and clinical spectrum", J Neurol Neurosurg Psychiatry, 83, pp.124~137 (2012)
  59. Hermann DM, "Brain-reactive β-amyloid antibodies in primary CNS angiitis with cerebral amyloid angiopathy", Neurology, 77, pp.503~505 (2011)
  60. Piazza F, "Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation : implications for amyloid-modifying therapies", Ann Neurol, 73, pp.449~458 (2013)
  61. DiFrancesco JC, "Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation : a case report", Neurology, 76, pp.842~844 (2011)
  62. Kimura A, "Corticosteroid therapy in a patient with cerebral amyloid angiopathy-related inflammation", J Neuroinflammation, 10, pp.39~ (2013)
  63. Sperling R, "Amyloid-related imaging abnormalities in patients with Alzheimer’s disease treated with bapineuzumab : a retrospective analysis", Lancet Neurol, 11, pp.241~249 (2012)
  64. DiFrancesco JC, "Anti-Aβ autoantibodies in amyloid related imaging abnormalities(ARIA) : candidate biomarker for immunotherapy in Alzheimer’s disease and cerebral amyloid angiopathy", Front Neurol, 6, pp.207~ (2015)
  65. Sperling RA, "Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials : recommendations from the Alzheimer’s Association Research Roundtable Workgroup", Alzheimers Dement, 7, pp.367~385 (2011)
  66. Salloway S, "A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease", Neurology, 73, pp.2061~2070 (2009)
  67. Söderberg L, "Lecanemab, aducanumab, and gantenerumab—binding profiles to different forms of amyloid-beta might explain efficacy and side effects in clinical trials for Alzheimer’s disease", Neurotherapeutics, 20, pp.195~206 (2023)
  68. Orgogozo JM, "Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization", Neurology, 61, pp.46~54 (2003)
  69. Ferrer I, "Neuropathology and pathogenesis of encephalitis following amyloidbeta immunization in Alzheimer’s disease", Brain Pathol, 14, pp.11~20 (2004)
  70. Bayer AJ, "Evaluation of the safety and immunogenicity of synthetic Abeta42(AN1792)in patients with AD", Neurology, 64, pp.94~101 (2005)
  71. Nicoll JA, "Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide : a case report", Nat Med, 9, pp.448~452 (2003)
  72. Williams G, "Histological studies in resorption of experimental amyloid", J Pathol Bacteriol, 94, pp.331~336 (1967)
  73. Suo Z, "Alzheimer’s beta-amyloid peptides induce inflammatory cascade in human vascular cells : the roles of cytokines and CD40", Brain Res, 807, pp.110~117 (1998)
  74. Heffernan AL, "The neurobiology and age-related prevalence of the ε4 allele of apolipoprotein E in Alzheimer’s disease cohorts", J Mol Neurosci, 60, pp.316~324 (2016)
  75. Ogura A, "A case of amyloid-β-related cerebral angiitis with ApoE ε4", ε2genotype, 2015, pp.55, 561~566
  76. Barger SW, "Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E", Nature, 388, pp.878~881 (1997)
  77. Renard D, "Cerebral amyloid angiopathy and cerebral amyloid angiopathyrelated inflammation : comparison of hemorrhagic and DWI MRI features", J Alzheimers Dis, 64, pp.1113~1121 (2018)
  78. Rannikmäe K, "Genetics of cerebral amyloid angiopathy : systematic review and meta-analysis", J Neurol Neurosurg Psychiatry, 84, pp.901~908 (2013)
  79. Masahito Yamada, "Cerebral Amyloid Angiopathy: Emerging Concepts", 대한뇌졸중영문학회지, 17(1), pp.17~30 (2015), 대한뇌졸중학회
  80. Fountain NB, "Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy : report of two cases and review of the literature", Neurology, 46, pp.190~197 (1996)
  81. Le Coz P, "Granulomatous angiitis and cerebral amyloid angiopathy presenting as a mass lesion", Neuropathol Appl Neurobiol, 17, pp.149~155 (1991)
  82. DiFrancesco JC, "Recurrence of cerebral amyloid angiopathy-related inflammation : a report of two cases from the iCAβ international network", J Alzheimers Dis, 46, pp.1071~1077 (2015)
  83. Ginsberg L, "Amyloid angiopathy and granulomatous angiitis of the central nervous system : a case responding to corticosteroid treatment", J Neurol, 235, pp.438~440 (1988)
  84. Geschwind MD, "Rapidly progressive dementia", Continuum(Minneap Minn), 22, pp.510~537 (2016)
  85. Paterson RW, "Diagnosis and treatment of rapidly progressive dementias", Neurol Clin Pract, 2, pp.187~200 (2012)
  86. Oh U, "Reversible leukoencephalopathy associated with cerebral amyloid angiopathy", Neurology, 62, pp.494~497 (2004)
  87. Chao CP, "Cerebral amyloid angiopathy : CT and MR imaging findings", Radiographics, 26, pp.1517~1531 (2006)
  88. Kotsenas AL, "Tumefactive cerebral amyloid angiopathy mimicking CNS neoplasm", AJR Am J Roentgenol, 200, pp.50~56 (2013)
  89. Cheng AL, "Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds", Stroke, 44, pp.2782~2786 (2013)
  90. Shams S, "SWI or T2*: which MRI sequence to use in the detection of cerebral microbleeds? The Karolinska imaging dementia study", AJNR Am J Neuroradiol, 36, pp.1089~1095 (2015)
  91. Maddox D, "Cerebral amyloid angiopathy with related inflammation masquerading as crescendo transient ischaemic attacks", Pract Neurol, 22, pp.216~219 (2022)
  92. Regenhardt RW, "Association between immunosuppressive treatment and outcomes of cerebral amyloid angiopathy-related inflammation", JAMA Neurol, 77, pp.1261~1269 (2020)
  93. Ishii M, "Amyloid β-related central nervous system angiitis presenting with an isolated seizure", Neurohospitalist, 4, pp.86~89 (2014)
  94. Briceno CE, "Cerebral amyloid angiopathy presenting as a mass lesion", Stroke, 18, pp.234~239 (1987)
  95. Greenberg SM, "Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy", Stroke, 28, pp.1418~1422 (1997)
  96. Emilio FM, "Mainly subarachnoid amyloid angiopathy with pseudotumoral course", Clin Neurol Neurosurg, 141, pp.89~91 (2016)
  97. Lasocki A, "Clinical and radiological evolution of cerebral amyloid angiopathy-related inflammation in the context of anti-PD-1immunotherapy", Melanoma Res, 30, pp.608~612 (2020)
  98. Sakaguchi H, "Cerebral amyloid angiopathy-related inflammation presenting with steroid-responsive higher brain dysfunction : case report and review of the literature", J Neuroinflammation, 8, pp.116~ (2011)

관련 논문AI추천

Cerebral Amyloid Angiopathy: Emerging ConceptsMasahito Yamada대한뇌졸중학회 · 대한뇌졸중영문학회지2015 · 제17권 제1호Pseudotumoral Presentation of Cerebral Amyloid-Beta Angiopathy: Case Report and Review of LiteratureCarlos Rugilo, Claudia Uribe Roca, Fabio Maximiliano Gonzalez, Gustavo Sevlever, Luciana Leon Cejas, Lucrecia Bandeo, Manuel Fernandez Pardal, Marta Ines Bala, Miguel Saucedo, Pablo Bonardo, Pablo Dezanzo, Rafael Torino, Ricardo Reisin, Sol Pacha대한신경정신의학회 · PSYCHIATRY INVESTIGATION2021 · 제18권 제6호Multimodal Imaging Findings of Cerebral Amyloid Angiopathy Related Inflammation With Unusual Clinical Manifestation: A Case Report박미나, 서상현, 안성준, 유영훈, 유한수, 이재훈, 주비오, Jalim Koo대한자기공명의과학회 · Investigative Magnetic Resonance Imaging2023 · 제27권 제1호Cerebral Amyloid Angiopathy: A Systematic ReviewAlessandro Biffi, Steven M. Greenberg대한신경과학회 · Journal of Clinical Neurology2011 · 제7권 제1호뇌 아밀로이드 혈관병증-관련염증 증례를 통해 분석한 뇌척수액 아밀로이드 베타 및 플로르베타벤 뇌 양전자 단층촬영 소견구용서, 김지연, 박윤직, 이재홍, 정희재, 조성양대한신경과학회 · 대한신경과학회지2021 · 제39권 제3호Cerebral Amyloid Angiopathy: An Undeniable Small Vessel DiseaseDongqi Yue, Jun Liu, Li-Tao Wang, Qiong Liu, Yi Fu대한뇌졸중학회 · 대한뇌졸중영문학회지2024 · 제26권 제1호

이 간행물의 다른 논문 (16건)

The Intersection of Technology and Humanity: Exploring the Ethics and Potential of Artificial Intelligence in Medicine김병조pp. 215-216Current Updates on the Diagnosis and Management of Multiple Sclerosis for the General NeurologistThomas Shoemaker, Edith L Graham, Archit B Baskaran, Elena Grebenciucovapp. 217-229Relationships of Low Serum Levels of Interleukin-10 With Poststroke Anxiety and Cognitive Impairment in Patients With Clinical Acute StrokeZhao-jian Ying, Yuan-Yuan Huang, Meng-Meng Shao, Chu-Huai Chi, Ming-Xia Jiang, Xianmei Li, Yan-Yan Zhu, Miao-Xuan Sun, Yu-Chen, Yi-Hui Chenpp. 242-250Relationships of Fall Risk With Frailty, Sarcopenia, and Balance Disturbances in Mild-to-Moderate Alzheimer’s DiseaseMeltem Halil, Zeynep Kahyaoğlu, İlker Boğa, Serdar Ceylan, Burcu Balam Doğu, Mustafa Cankurtaran, Merve Güner Oytun, Semra Topuz, Arzu Okyar Baş, Süheyla Çötelipp. 251-259Comparison Between 18F-Florapronol and 18F-Florbetaben Imaging in Patients With Cognitive Impairment이필휴, 백경원, Seun Jeon, 이영건, 예병석, 손영호, 박민철pp. 260-269
원문 보기